Multi-Omics Research on Angina Pectoris: A Novel Perspective DOI Creative Commons
Haiyang Chen, Lijun Zhang,

Meiyan Liu

et al.

Aging and Disease, Journal Year: 2024, Volume and Issue: unknown, P. 0 - 0

Published: Jan. 1, 2024

Angina pectoris (AP), a clinical syndrome characterized by paroxysmal chest pain, is caused insufficient blood supply to the coronary arteries and sudden temporary myocardial ischemia hypoxia. Long-term AP typically induces other cardiovascular events, including infarction heart failure, posing serious threat patient safety. However, AP's complex pathological mechanisms developmental processes introduce significant challenges in rapid diagnosis accurate treatment of its different subtypes, stable angina (SAP), unstable (UAP), variant (VAP). Omics research has contributed significantly revealing various diseases with development high-throughput sequencing approaches. The application multi-omics approaches effectively interprets systematic information on from perspective genes, RNAs, proteins, metabolites. Integrating introduces novel avenues for identifying biomarkers distinguish subtypes. This study reviewed articles related elaborate progress (including genomics, transcriptomics, proteomics, metabolomics), summarized their applications screening employed discriminate multiple delineated integration methods Finally, we discussed advantages disadvantages applying single-omics approach distinguishing diverse Our review demonstrated that technologies preferable quick precise three types, namely SAP, UAP, VAP.

Language: Английский

Novel research and future prospects of artificial intelligence in cancer diagnosis and treatment DOI Creative Commons
Chaoyi Zhang, Jin Xu,

Rong Tang

et al.

Journal of Hematology & Oncology, Journal Year: 2023, Volume and Issue: 16(1)

Published: Nov. 27, 2023

Research into the potential benefits of artificial intelligence for comprehending intricate biology cancer has grown as a result widespread use deep learning and machine in healthcare sector availability highly specialized datasets. Here, we review new approaches how they are being used oncology. We describe might be detection, prognosis, administration treatments introduce latest large language models such ChatGPT oncology clinics. highlight applications omics data types, offer perspectives on various types combined to create decision-support tools. also evaluate present constraints challenges applying precision Finally, discuss current may surmounted make useful clinical settings future.

Language: Английский

Citations

49

Microbiome as a biomarker and therapeutic target in pancreatic cancer DOI Creative Commons
Ghazaleh Pourali, Danial Kazemi,

Amir Shayan Chadeganipour

et al.

BMC Microbiology, Journal Year: 2024, Volume and Issue: 24(1)

Published: Jan. 5, 2024

Abstract Studying the effects of microbiome on development different types cancer has recently received increasing research attention. In this context, microbial content organs gastrointestinal tract been proposed to play a potential role in pancreatic (PC). Proposed mechanisms for pathogenesis PC include persistent inflammation caused by microbiota leading an impairment antitumor immune surveillance and altered cellular processes tumor microenvironment. The limited available diagnostic markers that can currently be used screening suggest importance composition as non-invasive biomarker clinical settings. Samples including saliva, stool, blood analyzed 16 s rRNA sequencing determine relative abundance specific bacteria. Studies have shown potentially beneficial prebiotics, probiotics, antibiotics, fecal transplantation, bacteriophage therapy altering diversity, subsequently improving treatment outcomes. review, we summarize impact PC, these microorganisms might biomarkers diagnosis determining prognosis patients. We also discuss novel methods being minimize or prevent progression dysbiosis modulating composition. Emerging evidence is supportive applying findings improve current therapeutic strategies employed PC.

Language: Английский

Citations

22

Advances in Precision Medicine Approaches for Colorectal Cancer: From Molecular Profiling to Targeted Therapies DOI Creative Commons

Neelakanta Sarvashiva Kiran,

Chandrashekar Yashaswini,

Rahul Maheshwari

et al.

ACS Pharmacology & Translational Science, Journal Year: 2024, Volume and Issue: 7(4), P. 967 - 990

Published: March 19, 2024

Precision medicine is transforming colorectal cancer treatment through the integration of advanced technologies and biomarkers, enhancing personalized effective disease management. Identification key driver mutations molecular profiling have deepened our comprehension genetic alterations in cancer, facilitating targeted therapy immunotherapy selection. Biomarkers such as microsatellite instability (MSI) DNA mismatch repair deficiency (dMMR) guide decisions, opening avenues for immunotherapy. Emerging liquid biopsies, artificial intelligence, machine learning promise to revolutionize early detection, monitoring, selection precision medicine. Despite these advancements, ethical regulatory challenges, including equitable access data privacy, emphasize importance responsible implementation. The dynamic nature with its tumor heterogeneity clonal evolution, underscores necessity adaptive strategies. future lies potential enhance patient care, clinical outcomes, understanding this intricate disease, marked by ongoing evolution field. current reviews focus on providing in-depth knowledge various diverse approaches utilized against at both biochemical levels.

Language: Английский

Citations

15

Precision medicine in colorectal cancer: Leveraging multi-omics, spatial omics, and artificial intelligence DOI

Zishan Xu,

Wei Li,

Xiangyang Dong

et al.

Clinica Chimica Acta, Journal Year: 2024, Volume and Issue: 559, P. 119686 - 119686

Published: April 23, 2024

Language: Английский

Citations

11

LC-MS/MS-based proteomics and metabolomics of HCT-116 colorectal cancer cells: A potential anticancer activity of atorvastatin DOI Creative Commons
Refat M. Nimer,

Hiba A. Nazazleh,

Belal Al‐Husein

et al.

Pharmacia, Journal Year: 2025, Volume and Issue: 72, P. 1 - 13

Published: Jan. 13, 2025

Colorectal cancer (CRC) is the third most prevalent tumor in men, second common women, and fourth leading cause of mortality worldwide. Statins reduce cholesterol levels by hampering function 3-hydroxy-3-methyl-glutaryl-CoA reductase enzymes synthesis. Strains have shown anticancer effects against CRC. However, statins’ mechanism yet unknown. Liquid chromatography–mass spectrometry (LC–MS)-based untargeted metabolomics proteomics were employed to study on CRC using cell line HCT-116. These approaches utilized identify potential underlying metabolic pathways proteins altered atorvastatin (a statin)-treated HCT-116 cells. Compared control, significantly numerous metabolites cells, including a reduction decanoylcarnitine octanoyl-L-carnitine biosynthesis metabolism amino acids like alanine citrate cycle. Proteomic showed that atorvastatin-treated cells expressed 127 differently from controls. Novel findings among them, such as centromere-associated protein E, cytochrome c oxidase subunit 6A1 mitochondrial, hyaluronan synthase 1. The indicate may characteristics highlight essential role understand complex relevant develop novel treatment targets.

Language: Английский

Citations

1

Advance computational tools for multiomics data learning DOI
Sheikh Mansoor,

Saira Hamid,

Thai Thanh Tuan

et al.

Biotechnology Advances, Journal Year: 2024, Volume and Issue: 77, P. 108447 - 108447

Published: Sept. 7, 2024

Language: Английский

Citations

8

Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response DOI
Christopher J.M. Williams,

Allyson Peddle,

Pashtoon Murtaza Kasi

et al.

Nature Reviews Clinical Oncology, Journal Year: 2024, Volume and Issue: 21(12), P. 839 - 851

Published: Sept. 24, 2024

Language: Английский

Citations

8

A comprehensive multi-omics study reveals potential prognostic and diagnostic biomarkers for colorectal cancer DOI
Mohita Mahajan,

Subodh Dhabalia,

Tirtharaj Dash

et al.

International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: 303, P. 140443 - 140443

Published: Feb. 3, 2025

Language: Английский

Citations

0

Comprehensive Bioinformatics Analysis of Glycosylation-Related Genes and Potential Therapeutic Targets in Colorectal Cancer DOI Open Access
Po-Kai Chuang, Kai‐Fu Chang,

Chih-Hsuan Chang

et al.

International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(4), P. 1648 - 1648

Published: Feb. 14, 2025

Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide, characterized by high incidence and poor survival rates. Glycosylation, fundamental post-translational modification, influences protein stability, signaling, tumor progression, with aberrations implicated in immune evasion metastasis. This study investigates the role glycosylation-related genes (Glycosylation-RGs) CRC using machine learning bioinformatics. Data from The Cancer Genome Atlas (TCGA) Molecular Signatures Database (MSigDB) were analyzed to identify 67 differentially expressed Glycosylation-RGs. These used classify patients into two subgroups distinct outcomes, highlighting their prognostic value. Weighted gene coexpression network analysis (WGCNA) revealed key modules associated traits, including pathways like glycan biosynthesis PI3K-Akt signaling. A machine-learning-based model demonstrated strong predictive performance, stratifying high- low-risk groups significant differences. Additionally, correlations between risk scores cell infiltration, providing insights microenvironment. Drug sensitivity identified potential therapeutic agents, Trametinib, SCH772984, Oxaliplatin, showing differential efficacy groups. findings enhance our understanding glycosylation CRC, identifying it as critical factor disease progression promising target for future strategies.

Language: Английский

Citations

0

Advanced segmentation method for integrating multi-omics data for early cancer detection DOI Creative Commons

S Sangeetha,

Sandeep Kumar Mathivanan,

M Azath

et al.

Egyptian Informatics Journal, Journal Year: 2025, Volume and Issue: 29, P. 100624 - 100624

Published: Feb. 15, 2025

Language: Английский

Citations

0